Breast cancer more likely to be advanced stage disease at diagnosis in women with diabetes
the ONA take:
A new study by the Institute for Clinical Evaluative Sciences (ICES) and Women’s College Hospital demonstrates that breast cancer in women with diabetes is more likely to be advanced stage at diagnosis.
The researchers reviewed cases of new invasive breast cancer diagnoses in women ages 20 to 105 years made between 2007 and 2012.
In the study, 6,115 of more 38,000 women (15.9%) had diabetes. These women were 14% more likely to present with stage II breast cancer, 21% more likely to present with stage III breast cancer, and 16% more likely to present with stage IV disease than to present with stage I.
Women with diabetes also had higher risk of lymph node metastases. In addition, mammography rates were lower among women with diabetes, possibly accounting for later stage disease at diagnosis.
Stage II or III breast cancer at diagnosis translates into a 15% decrease in 5-year survival at the time of diagnosis for these patients.
The researchers suggest that breast cancer screening practices may need to be modified for women with diabetes to reduce later-stage detection.
Breast cancer in women with diabetes is more likely to be advanced stage at diagnosis.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|